Related Experiment Video
Updated: Feb 1, 2026

08:07
Investigating Stress-relaxation and Failure Responses in the Trachea
Published on: October 18, 2022
2.2K
A Case Report of End-of-Dosage Failure With Buprenorphine Patch
Samiddhi D Weerasiri1, Leslie R Siegel2, Regina M Mackey3
1Internal Medicine Resident (S.D.W.), Mayo Clinic, Rochester, Minnesota, USA.
Journal of Pain and Symptom Management
|January 30, 2026
Summary
This case report details the first instance of end-of-dosage failure with a buprenorphine patch. Patients experiencing a wearing-off effect may benefit from a shorter, five-day dosing interval for sustained pain relief.
Area of Science:
- Palliative Care
- Pain Management
- Oncology
Background:
- Effective pain management is crucial in palliative care.
- This report addresses end-of-dosage failure with buprenorphine patches, a novel finding.
- Current knowledge gaps exist regarding buprenorphine patch efficacy in all patients.
Purpose of the Study:
- To report the first case of end-of-dosage failure with a buprenorphine patch.
- To challenge the assumption of seven-day analgesic efficacy for buprenorphine patches.
- To highlight the need for individualized pain management strategies.
Main Methods:
- A case report of a 72-year-old male with metastatic adenocarcinoma.
- Patient transitioned from tramadol to a buprenorphine patch (5mcg/hr).
- Observed wearing-off effect by day five of buprenorphine patch treatment.
Main Results:
- The patient experienced consistent wearing-off of buprenorphine analgesic effect by day five.
- Exchanging the patch on day five resolved abdominal pain and improved quality of life.
- This case demonstrates end-of-dosage failure with buprenorphine patch therapy.
Conclusions:
- Buprenorphine patches may not provide seven-day analgesic efficacy for all patients.
- Screening for premature wearing-off of buprenorphine effect is recommended.
- A reduced five-day dosing interval may improve sustained analgesia for some patients.
Related Concept Videos
Dosage Regimen: Multiple Oral Dosage
255
Understanding how a drug's concentration fluctuates within the body over time is crucial in pharmacokinetics, particularly with multiple oral doses. A graphical representation of multiple oral dosages provides insight into these dynamics. Typical accumulation curves of a drug's concentration in the body reveal a sawtooth pattern, indicating periodic peaks and troughs correlating with each dose administration and the drug's subsequent elimination.The plasma concentration at any time during an...
255
Dosage Compensation
7.3K
In animals, gender is determined by the number and type of sex chromosome. For example, human females have two X chromosomes, and males have one X and one Y chromosome, whereas C.elegans with one X chromosome is a male, and the one with two X chromosomes is a hermaphrodite.
In addition to sexual development, the X chromosome has genes involved in autosomal functions such as brain development and the immune system. Therefore, males and females with distinct numbers of X chromosomes will...
In addition to sexual development, the X chromosome has genes involved in autosomal functions such as brain development and the immune system. Therefore, males and females with distinct numbers of X chromosomes will...
7.3K
Dosage Regimen: Individualization
184
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
184
Long-patch Base Excision Repair
8.0K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
8.0K
Drug Dosage Regimen: Overview
4.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.5K
Dosage Regimen: Fixed Dose
2.4K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.4K

